In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Consumer devices to remain within Swedish pharma benefits scheme

This article was originally published in Clinica

Executive Summary

Consumer medical devices, such as stoma care products, will remain part of the Swedish pharmaceutical benefits scheme (LMF). According to an agreement between the government and the Swedish association of county councils (LF) earlier this month, the scheme will not to be altered in the near future, despite the appointment of a new health minister. Consumer devices will thus continue to be subsidised.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT059685

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel